So, Brigatinib is this medicine that stops a specific type of lung cancer from spreading. It works by shutting down a protein called ALK that’s involved in cancer’s spread. You can get this med in three strengths: 30, 90, and 180 milligrams, all as those tablets with a film coating.
Doctors usually start with 90 mg a day for the first week, then you keep at 180 mg each day after that. They come in bottles with 30 tablets in each. This ALK inhibitor focuses on a specific change in the ALK gene, which affects about 5% of lung cancer patients.
And guess what? The FDA has okayed it for use in the U.S.
